PharmTech

How the Wegovy Pill Approval Reshapes Solid Dosage Manufacturing Strategy

The Wegovy pill's approval signifies a shift from injectable to oral dosage forms, driven by patient preference for convenience and requiring advanced formulation techniques. Rapid scaling of ...
Contract Pharma

OSD Early Stage: Getting Oral Products into Clinic Early

In the fast-paced world of drug development, time is often the most precious commodity. For biotech companies working on oral ...
Morningstar

Bora Pharmaceuticals and Corealis Pharma Forge Strategic Alliance to Deliver Seamless, End-to-End Oral Solid Dose Development

MAPLE GROVE, Minn., Dec. 9, 2025 /PRNewswire/ -- Bora Pharmaceuticals Co., Ltd. ("Bora", TWSE: 6472), a global leader in pharmaceutical manufacturing, and Corealis ...
Business Wire

United States Oral Solid Dosage Contract Manufacturing Research Report 2023: Market to Reach $16.42 Billion by 2030 - One-Stop-Shop Solutions Transforming the Industry ...

DUBLIN--(BUSINESS WIRE)--The "U.S. Oral Solid Dosage Contract Manufacturing Market Size, Share & Trends Analysis Report By Product Type (Tablets, Capsules), By Mechanism (Controlled-, ...
Contract Pharma

Techceuticals Releases 2026 Schedule for Hands-On Solid Dosage Manufacturing Training

Techceuticals has announced its 2026 training schedule for solid dosage manufacturing, featuring a full lineup of two-day, ...
Finanznachrichten

Bora Pharmaceuticals and Corealis Pharma Forge Strategic Alliance to Deliver Seamless, End-to-End Oral Solid Dose Development

Partnership creates simplified pathway from early development to commercial launch MAPLE GROVE, Minn., Dec. 9, 2025 /PRNewswire/ -- Bora Pharmaceuticals Co., Ltd. ("Bora", TWSE: 6472), a global leader ...